CD34(+) Stem Cell Therapy in Non-Ischemic Dilated Cardiomyopathy Patients. Clin Pharmacol Ther. 2013..
Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc Natl Acad Sci U S A. 2013.
Generation of Human iPSCs from Human Peripheral Blood Mononuclear Cells Using Non-integrative Sendai Virus in Chemically Defined Conditions. Methods Mol Biol. 2013;1036:81-88..
Induced Pluripotency of Human Prostatic Epithelial Cells. PLoS One. 2013;8(5):e64503..
Chemically defined generation of human cardiomyocytes. Nat Methods. 2014.
Effects of Transendocardial CD34+ Cell Transplantation in Patients With Ischemic Cardiomyopathy. Circ Cardiovasc Interv. 2014..
Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment. Sci Rep. 2015;5:10902.
Human Engineered Heart Muscles Engraft and Survive Long-Term in a Rodent Myocardial Infarction Model. Circ Res. 2015.
Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest. 2015;125(7):2551-2557..
Immune Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients with Dilated Cardiomyopathy. J Card Fail. 2015..
Induced Pluripotent Stem Cells. JAMA. 2015;313(16):1613-1614..
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review. JAMA Cardiol. 2016..
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016.
Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases. Curr Opin Cardiol. 2016..
iPSC Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity. Am J Respir Crit Care Med. 2016.
Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. JAMA Cardiol. 2016..
Disease modelling and drug discovery for hypertrophic cardiomyopathy using pluripotent stem cells: how far have we come?. Eur Heart J. 2018..
Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant. J Am Coll Cardiol. 2018;72(1):62-75..
Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models. Adv Drug Deliv Rev. 2018..
Systems-Wide Approaches in Induced Pluripotent Stem Cell Models. Annu Rev Pathol. 2018..
A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources. J Physiol. 2019..
Generation of Endothelial Cells From Human Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol. 2019;39(7):1317-1329..